Efficacy of Oral Vancomycin in Preventing Recurrent Clostridium difficile Infection in Patients Treated With Systemic Antimicrobial Agents Reply

Van Hise Nicholas W.; Manian Farrin A.

首页> 外文期刊>Clinical infectious diseases >Efficacy of Oral Vancomycin in Preventing Recurrent Clostridium difficile Infection in Patients Treated With Systemic Antimicrobial Agents Reply

【24h】

Efficacy of Oral Vancomycin in Preventing Recurrent Clostridium difficile Infection in Patients Treated With Systemic Antimicrobial Agents Reply

机译：口服万古霉素在治疗系统抗菌药物治疗患者中预防复发性梭菌性艰难梭菌性的疗效

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Clinical infectious diseases》 |2016年第10期|共2页
作者
Van Hise Nicholas W.; Manian Farrin A.;
展开▼
作者单位

Edward Elmhurst Hosp Dept Pharm Naperville IL USA;

Harvard Med Sch Massachusetts Gen Hosp Dept Med Boston MA USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类传染病;
关键词

相似文献

外文文献
中文文献
专利

1. Efficacy of Oral Vancomycin in Preventing Recurrent Clostridium difficile Infection in Patients Treated With Systemic Antimicrobial Agents Reply [J] . Van Hise Nicholas W., Manian Farrin A. Clinical infectious diseases . 2016,第10期

机译：口服万古霉素预防全身性抗菌药物治疗的患者难治性艰难梭菌感染的疗效回复
2. Efficacy of Oral Vancomycin in Preventing Recurrent Clostridium difficile Infection in Patients Treated With Systemic Antimicrobial Agents [J] . Van Hise Nicholas W., Bryant Alex M., Hennessey Erin K., Clinical infectious diseases . 2016,第5期

机译：口服万古霉素预防全身性抗微生物药治疗的患者难治性梭状芽胞杆菌感染的功效
3. Efficacy of Oral Vancomycin in Preventing Recurrent Clostridium difficile Infection in Patients Treated With Systemic Antimicrobial Agents [J] . Cheng Matthew P., Parkes Leighanne O., Lee Todd C. Clinical infectious diseases . 2016,第10期

机译：口服万古霉素预防全身性抗微生物药治疗的患者难治性梭状芽胞杆菌感染的功效
4. Novel Peptide-based Antimicrobial Agents for the Treatment of Clostridium Difficile Associated Disease [C] . David A. Kennedy, Marc Devocelle American Peptide Symposium . 2009

机译：基于新型肽的抗微生物剂，用于治疗梭菌差异相关疾病
5. Molecular characterization of vancomycin-intermediate Staphlococcus aureus (VISA) and heterogeneous vancomycin-intermediate Staphlococcus aureus (hVISA) in patients with recurrent infections. [D] . Carrette, Albert. 2010

机译：反复感染患者中万古霉素中间金黄色葡萄球菌（VISA）和异种万古霉素中间金黄色葡萄球菌（hVISA）的分子特征。
6. 2421. Efficacy of Secondary Prophylaxis with Oral Vancomycin in Preventing Recurrent Clostridioides difficile Infections in Patients Receiving Systemic Antibiotics [O] . Kelly E Pillinger, Jason K Lew, Kelly M Conn, -1

机译：2421.口服万古霉素二级预防对接受系统抗生素的患者预防难治性梭状芽胞杆菌感染的预防作用
7. Efficacy of Oral Vancomycin in Preventing Recurrent Clostridium difficile Infection in Patients Treated With Systemic Antimicrobial Agents [O] . Matthew P. Cheng, Leighanne O. Parkes, Todd C. Lee 2016

机译：口服万古霉素在全身抗微生物剂治疗患者中预防复发性梭菌性感染的疗效

Efficacy of Oral Vancomycin in Preventing Recurrent Clostridium difficile Infection in Patients Treated With Systemic Antimicrobial Agents Reply

著录项

相似文献

相关主题

期刊订阅